Core Insights - Mindray Medical reported a revenue of 16.743 billion yuan and a net profit attributable to shareholders of 5.069 billion yuan for the first half of 2025 [1] Group 1: International Business Performance - The company's international business generated revenue of 8.332 billion yuan, accounting for 50% of total revenue, with rapid growth in developing countries [1] - Mindray maintains a top-three market share globally in products such as monitors, anesthesia machines, ventilators, defibrillators, blood cell analyzers, and ultrasound products [1] - The company anticipates accelerated growth in international business in the second half of 2025, particularly in the in-vitro diagnostics segment [1] Group 2: Domestic Business Outlook - With the recovery of medical equipment bidding activities in the first half of 2025, the domestic market is expected to see a turning point in the third quarter [1] - Preliminary estimates suggest that the company's overall revenue will achieve year-on-year growth in the third quarter, continuing a trend of quarter-on-quarter improvement in revenue [1]